anti-TL1A antibodies (NIAMS)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-TL1A antibodies (NIAMS)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyDiagnostic agent (In vivo)
Mechanisms of ActionTumor necrosis factor superfamily member 15 inhibitors
TargetsTumor necrosis factor superfamily member 15
Therapy Area/IndicationsInflammatory Bowel DiseasesArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Arthritis And Musculoskeletal And Skin Diseases
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthNational Institute Of Arthritis And Musculoskeletal And Skin Diseases
Active IndicationsN/A
Inactive IndicationsInflammatory Bowel DiseasesArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A